United Therapeutics's board approves new $2B repurchase authorization

Core Viewpoint - United Therapeutics Corporation has initiated a stock repurchase program with a total authorization of up to $2 billion for buybacks over the next year [1] Group 1: Stock Repurchase Program - The board of directors of United Therapeutics Corporation has approved a stock repurchase program [1] - The company plans to execute buybacks amounting to $2 billion within the next year [1] Group 2: ASR Agreements - United Therapeutics has entered into Accelerated Share Repurchase (ASR) agreements with Citibank [1] - The initial ASR agreement is valued at $1.5 billion [1]